4 research outputs found
Himbacine-Derived Thrombin Receptor Antagonists: C<sub>7</sub>‑Aminomethyl and C<sub>9a</sub>-Hydroxy Analogues of Vorapaxar
We have synthesized several C<sub>7</sub>-aminomethyl analogues
of vorapaxar that are potent PAR-1 antagonists. Many of these analogues
showed excellent in vitro binding affinity and pharmacokinetics profile
in rats. Compound <b>6a</b> from this series showed excellent
PAR-1 activity (<i>K</i><sub>i</sub> = 5 nM). We have also
synthesized a C<sub>9a</sub>-hydroxy analogue of vorapaxar, which
showed very good PAR-1 affinity (<i>K</i><sub>i</sub> =
19.5 nM) along with excellent rat pharmacokinetic profile and ex vivo
efficacy in the cynomolgus monkey
Himbacine-Derived Thrombin Receptor Antagonists: C<sub>7</sub>‑Spirocyclic Analogues of Vorapaxar
We
have synthesized several C<sub>7</sub>-spirocyclic analogues of vorapaxar
and evaluated their in vitro activities against PAR-1 receptor. Some
of these analogues showed activities and rat plasma levels comparable
to vorapaxar. Compound <b>5c</b> from this series showed excellent
PAR-1 activity (<i>K</i><sub>i</sub> = 5.1 nM). We also
present a model of these spirocyclic compounds docked to the PAR-1
receptor based on the X-ray crystal structure of vorapaxar bound to
PAR-1 receptor. This model explains some of the structure–activity
relationships in this series